GlaxoSmithkline Consumer Nigeria plc (GSK Nigeria) has announced a strong growth in its audited results for the year ended 31 December 2014, even as it approved bonus shares for its shareholders.

The company also declared a N717.5 million dividend for its shareholders for the year ended December 2014.

Speaking at the 44th Annual General Meeting (AGM) held in Lagos, Edmund Onuzo, Chairman GSK Nigeria Board of Directors stated that although the year 2014 was challenging, the company remains committed in ensuring shareholders get the best returns on their investments.